• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本肝细胞癌发病率的变化

Changing incidence of hepatocellular carcinoma in Japan.

作者信息

Okuda K, Fujimoto I, Hanai A, Urano Y

出版信息

Cancer Res. 1987 Sep 15;47(18):4967-72.

PMID:3040235
Abstract

A trend in the incidence of hepatocellular carcinoma (HCC) in Japan was studied from the data of the Osaka Cancer Registry (population, 8,512,351 in 1981) for the period of 1963-1983, the Vital Statistics of Japan, Ministry of Health and Welfare, and the Japan Autopsy Registry which contained 594,132 individually filed cases in the 26-year period from 1958 to 1983. Both cancer registry data and autopsy records showed a more than 2-fold increase in HCC incidence, particularly in the last 10 years or so, among males and a less pronounced increase in females. The same trend was borne out by the cancer registries of Nagasaki City and Miyagi Prefecture and the Vital Statistics. When studied with the autopsy data, it was found that the numbers of autopsies for cirrhosis without HCC and autopsies for HCC (with and without cirrhosis) were about the same in 1958-1961 and that currently (1980-1983) the latter is about 2 times the former. As one of the possible causes of increase in HCC incidence other than prolonged survival of patients with cirrhosis, chronic non-A, non-B hepatitis is discussed.

摘要

利用大阪癌症登记处(1981年人口为8512351)1963 - 1983年期间的数据、日本厚生省的生命统计数据以及日本尸检登记处(在1958年至1983年的26年期间包含594132份单独存档的病例),对日本肝细胞癌(HCC)的发病率趋势进行了研究。癌症登记数据和尸检记录均显示,男性HCC发病率增加了2倍多,尤其是在过去10年左右,而女性的增加幅度较小。长崎市和宫城县的癌症登记处以及生命统计数据也证实了这一趋势。当与尸检数据一起研究时发现,1958 - 1961年期间无HCC的肝硬化尸检数量与HCC(有或无肝硬化)的尸检数量大致相同,而目前(1980 - 1983年)后者约为前者的2倍。作为HCC发病率增加的可能原因之一,除了肝硬化患者的生存期延长外,还讨论了慢性非甲非乙型肝炎。

相似文献

1
Changing incidence of hepatocellular carcinoma in Japan.日本肝细胞癌发病率的变化
Cancer Res. 1987 Sep 15;47(18):4967-72.
2
Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review.墨西哥的肝细胞癌和肝硬化:25年尸检回顾
Hepatogastroenterology. 1997 Sep-Oct;44(17):1401-3.
3
Incidence of hepatocellular carcinoma in Italy: what could we learn from autoptic studies?意大利肝细胞癌的发病率:我们能从尸检研究中学到什么?
Ital J Gastroenterol. 1991 Sep-Oct;23(7):448-51.
4
Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan.日本长崎县肝细胞癌发病率的长期趋势。
Oncol Rep. 2009 Jan;21(1):223-7.
5
Time trends in the incidence of hepatocellular carcinoma in liver cirrhosis. A retrospective necropsy study in a large Romanian town (1973-1992).
Rom J Intern Med. 1996 Jan-Jun;34(1-2):85-90.
6
Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.肝细胞癌的临床特征及尸检对诊断的影响。来自低流行区的530例病例研究。
Hepatogastroenterology. 2005 Nov-Dec;52(66):1798-802.
7
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.原发性胆汁性肝硬化中的肝细胞癌及其对预后的影响。
Hepatology. 1997 Nov;26(5):1138-42. doi: 10.1002/hep.510260508.
8
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.澳大利亚新南威尔士州乙型肝炎相关肝细胞癌的预测因素与生存率
J Gastroenterol Hepatol. 2009 Mar;24(3):436-42. doi: 10.1111/j.1440-1746.2008.05577.x. Epub 2008 Oct 21.
9
Incidence of hepatocellular carcinoma in the Trieste area over a 15-year period (1968-1982).
Appl Pathol. 1984;2(1):22-7.
10
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.代偿期病毒性肝硬化患者肝细胞癌的发病率
Cancer. 1999 May 15;85(10):2132-7.

引用本文的文献

1
Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line.查尔酮环氧化物类似物作为选择性COX-II抑制剂在人肝癌细胞系中的细胞毒性作用评估
J Pharmacopuncture. 2017 Sep;20(3):207-212. doi: 10.3831/KPI.2017.20.024. Epub 2017 Sep 30.
2
Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.2001 - 2009年美国不同种族和分期的肝癌生存率:CONCORD - 2研究结果
Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5059-5078. doi: 10.1002/cncr.30820.
3
Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapy.
肝动脉灌注化疗前后超声造影评估门静脉癌栓型肝细胞癌
J Med Ultrason (2001). 2010 Jul;37(3):137-41. doi: 10.1007/s10396-010-0259-6. Epub 2010 Apr 10.
4
Risk factors for hepatocellular carcinoma in India.印度肝细胞癌的危险因素。
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S34-42. doi: 10.1016/j.jceh.2014.02.155. Epub 2014 Apr 13.
5
Glycosylation and liver cancer.糖基化与肝癌
Adv Cancer Res. 2015;126:257-79. doi: 10.1016/bs.acr.2014.11.005. Epub 2015 Feb 7.
6
Hepatocellular carcinoma in the world and the middle East.全球及中东地区的肝细胞癌
Middle East J Dig Dis. 2010 Jan;2(1):31-41.
7
Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma.外周血单个核细胞中的1型干扰素受体可能预测晚期肝细胞癌动脉内5-氟尿嘧啶+干扰素治疗的反应。
Hepat Med. 2011 Apr 26;3:45-52. doi: 10.2147/HMER.S19695. eCollection 2011.
8
Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.印度北部旁遮普邦一家三级护理医院的肝细胞癌概况。
Indian J Gastroenterol. 2014 Jan;33(1):35-40. doi: 10.1007/s12664-013-0373-7. Epub 2013 Sep 6.
9
A case of hepatocellular carcinoma with portal vein tumor thrombosis successfully treated by a combination of intra-arterial infusion 5-fluorouracil, cisplatin, and systemic interferon-α therapies.1例门静脉瘤栓型肝细胞癌经动脉内灌注5-氟尿嘧啶、顺铂及全身干扰素-α联合治疗成功治愈。
Int Surg. 2012 Jul-Sep;97(3):230-4. doi: 10.9738/CC24.1.
10
Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).肝动脉灌注化疗治疗晚期肝细胞癌的毒性与疗效(综述)
Oncol Lett. 2012 Feb;3(2):259-263. doi: 10.3892/ol.2011.469. Epub 2011 Nov 2.